NCT01750866 Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT01718353 Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Status COMPLETED Phase PHASE2
NCT01717898 A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01717053 Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer Status COMPLETED Phase PHASE2
NCT01715285 A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) Status COMPLETED Phase PHASE3
NCT01714817 Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis Status TERMINATED Phase PHASE3
NCT01711827 A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01695135 A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy Status COMPLETED Phase PHASE3
NCT01692483 Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer Status WITHDRAWN Phase N/A
NCT01685268 A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate Status COMPLETED Phase PHASE1/PHASE2
NCT01685125 Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Status UNKNOWN Phase PHASE2
NCT01683994 Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01683552 Aprepitant in the Management of Biological Therapies-related Severe Pruritus Status COMPLETED Phase PHASE2
NCT01681433 OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone Status TERMINATED Phase PHASE2
NCT01676415 Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Status TERMINATED Phase PHASE4
NCT01671423 Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis Status COMPLETED Phase NA